Transgenic mice for in vivo epigenome editing with CRISPR-based systems
Journal article
Gemberling MP. et al, (2021), Nature Methods
Genome-Editing Strategies for Treating Human Retinal Degenerations
Journal article
Quinn J. et al, (2021), Human Gene Therapy, 32, 247 - 259
The Potential Benefit of Expedited Development and Approval Programs in Precision Medicine.
Journal article
Kantor A. and Haga SB., (2021), J Pers Med, 11
Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
Journal article
Han RC. et al, (2021), Expert Opinion on Orphan Drugs, 9, 13 - 24
CRISPR genome engineering for retinal diseases
Chapter
Kantor A. et al, (2021), Progress in Molecular Biology and Translational Science
CRISPR-Cas9 DNA Base-Editing and Prime-Editing.
Journal article
Kantor A. et al, (2020), Int J Mol Sci, 21
Comparison of Cas9 Orthologues for Gene Suppression Activity
Conference paper
Kantor A. et al, (2020), MOLECULAR THERAPY, 28, 103 - 104
Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing
Journal article
Haga SB. and Kantor A., (2018), Health Affairs, 37, 717 - 723